RecruitingNot ApplicableNCT05320835

A Setting Focus Overdose Prevention Intervention

A Geospatial Analysis of Hotspots and Targeted Injection Settings Pilot Intervention for HIV Prevention Among People Who Inject Drugs in Baltimore, Maryland

Sponsor

Johns Hopkins Bloomberg School of Public Health

Enrollment

285 participants

Start Date

Apr 30, 2022

Study Type

INTERVENTIONAL

Conditions

HIV Infections HCV Drug Overdose

Summary

A pilot injection-setting targeted peer-driven intervention to reduce HIV and hepatitis C virus transmission and overdose risk behaviors among people who inject drugs (PWID).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests a community-based overdose prevention program for people who use drugs, focusing on distributing naloxone (a life-saving overdose reversal medicine) and teaching bystanders how to respond to an overdose. **You may be eligible if...** - You are a person who uses drugs or knows someone who does - You are at risk of witnessing or experiencing an overdose - You are 18 or older - You live in or frequent the target community area **You may NOT be eligible if...** - You are under 18 - You are not willing to participate in training or follow-up Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.